April 8,Aier Eye HospitalThe announcement stated that its wholly-owned subsidiary, Shannan Zhilian Medical Information Technology Co., Ltd., intends to indirectly invest in the equity of Qihoo 360 Technology Co., Ltd. by participating as an investor in Tianjin Xinxinsheng Equity Investment Partnership (Limited Partnership). The subscribed capital commitment for this investment is RMB equivalent to USD 30.324 million. This matter was reviewed and approved at the 43rd meeting of the third Board of Directors held on April 6, 2016.
Tianjin Xinxinsheng Investment was established on November 23, 2015, with Qihuo Hesheng serving as the executive partner. The firm will participate in the privatization project of Qihoo 360 to seek investment returns. All partners contribute capital to the partnership in RMB cash. Shannan Zhilian will become a limited partner of Xinxinsheng Investment.
Under the plan, Tianjin Xinxinsheng Investment, in which Aier Eye Hospital participates as an investor, will hold an 11.44% stake in Qihoo 360 upon completion of the privatization, making it the second-largest shareholder after Zhou Hongyi.
In March 2011, Qihoo 360 was listed on the New York Stock Exchange. The company’s current plan to return to the A-share market represents the largest-scale delisting and relisting of a U.S.-listed Chinese stock by a domestic internet enterprise to date. Meanwhile,Aier Eye HospitalThe wholly-owned subsidiary, Shannan Zhilian, indirectly invested in the equity of Qihoo 360 by participating in the investment of Xinxinsheng Investment. This move is expected to generate substantial capital appreciation gains, thereby enhancing the company’s profitability and aligning with the interests of all shareholders.